Orthofix Q1 sales bring mild growth: 6 notes

Spinal Tech

Orthofix on May 6 posted a slight revenue increase in the first quarter of 2022.

Six things to know:

1. Overall revenue was about the same as the first quarter of 2022. Total sales were $106.4 million, a 1 percent increase year over year, according to a news release.

2. The spinal implants segment saw the largest year-over-year increase, at 3.6 percent. Spinal implant sales were $26.6 million.

3. Biologics sales rose 2.9 percent with $14.1 million.

4. The only segment that saw a decrease in quarterly sales was bone growth therapies, at $41.9 million, a 2.3 percent dip year over year.

5. Global orthopedic sales of $23.8 million represented a 2.2 percent increase year over year. Global spine sales remained about the same as the same period last year with a 0.4 percent increase.

6. Highlights of Orthofix's first quarter included an FDA grant for the AccelStim bone growth stimulator and FDA clearance for the TrueLok EVO ring fixation system.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers